News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
334,831 Results
Type
Article (23279)
Company Profile (304)
Press Release (311248)
Multimedia
Podcasts (53)
Webinars (7)
Section
Business (95306)
Career Advice (1324)
Deals (16143)
Drug Delivery (65)
Drug Development (55351)
Employer Resources (95)
FDA (7298)
Job Trends (6783)
News (171068)
Policy (13298)
Tag
Academia (1426)
Accelerated approval (3)
Adcomms (21)
Allergies (61)
Alliances (25529)
ALS (72)
Alzheimer's disease (1014)
Antibody-drug conjugate (ADC) (119)
Approvals (7291)
Artificial intelligence (169)
Autoimmune disease (22)
Automation (5)
Bankruptcy (133)
Best Places to Work (5825)
BIOSECURE Act (10)
Biosimilars (68)
Biotechnology (252)
Bladder cancer (71)
Brain cancer (22)
Breast cancer (199)
Cancer (1708)
Cardiovascular disease (147)
Career advice (1097)
Career pathing (19)
CAR-T (133)
Cell therapy (363)
Cervical cancer (10)
Clinical research (44776)
Collaboration (616)
Compensation (282)
Complete response letters (19)
COVID-19 (1611)
CRISPR (44)
C-suite (189)
Cystic fibrosis (80)
Data (1725)
Decentralized trials (1)
Denatured (11)
Depression (43)
Diabetes (186)
Diagnostics (2698)
Digital health (6)
Diversity (3)
Diversity, equity & inclusion (24)
Drug discovery (97)
Drug pricing (70)
Drug shortages (15)
Duchenne muscular dystrophy (94)
Earnings (36805)
Editorial (38)
Employer branding (13)
Employer resources (87)
Events (54970)
Executive appointments (512)
FDA (8190)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (566)
Gene editing (103)
Generative AI (14)
Gene therapy (280)
GLP-1 (495)
Government (1813)
Grass and pollen (2)
Guidances (95)
Healthcare (8842)
Huntington's disease (24)
IgA nephropathy (26)
Immunology and inflammation (119)
Indications (21)
Infectious disease (1696)
Inflammatory bowel disease (131)
Inflation Reduction Act (9)
Influenza (26)
Intellectual property (70)
Interviews (276)
IPO (8536)
IRA (31)
Job creations (1288)
Job search strategy (885)
Kidney cancer (10)
Labor market (21)
Layoffs (288)
Leadership (18)
Legal (2185)
Liver cancer (37)
Lung cancer (240)
Lymphoma (112)
Machine learning (7)
Management (32)
Manufacturing (196)
MASH (64)
Medical device (4313)
Medtech (4314)
Mergers & acquisitions (7995)
Metabolic disorders (517)
Multiple sclerosis (60)
NASH (15)
Neurodegenerative disease (90)
Neuropsychiatric disorders (28)
Neuroscience (1490)
NextGen: Class of 2025 (2922)
Non-profit (1509)
Now hiring (22)
Obesity (273)
Opinion (200)
Ovarian cancer (67)
Pain (59)
Pancreatic cancer (66)
Parkinson's disease (133)
Partnered (14)
Patents (148)
Patient recruitment (90)
Peanut (39)
People (29528)
Pharmaceutical (49)
Pharmacy benefit managers (14)
Phase I (15255)
Phase II (20603)
Phase III (13741)
Pipeline (1007)
Policy (105)
Postmarket research (1092)
Preclinical (6498)
Press Release (33)
Prostate cancer (74)
Psychedelics (37)
Radiopharmaceuticals (226)
Rare diseases (328)
Real estate (1914)
Recruiting (41)
Regulatory (10670)
Reports (22)
Research institute (1297)
Resumes & cover letters (233)
Rett syndrome (4)
RNA editing (5)
RSV (17)
Schizophrenia (69)
Series A (106)
Series B (70)
Service/supplier (1)
Sickle cell disease (45)
Special edition (15)
Spinal muscular atrophy (129)
Sponsored (24)
Startups (2253)
State (1)
Stomach cancer (11)
Supply chain (35)
Tariffs (28)
The Weekly (41)
Vaccines (370)
Venture capitalists (37)
Weight loss (178)
Women's health (21)
Worklife (11)
Date
Last 7 days (626)
Last 30 days (1914)
Last 365 days (21534)
2025 (7763)
2024 (23072)
2023 (25349)
2022 (33394)
2021 (34554)
2020 (30199)
2019 (21668)
2018 (15929)
2017 (16833)
2016 (15057)
2015 (17986)
2014 (13130)
2013 (9497)
2012 (9776)
2011 (9965)
2010 (9204)
Location
Africa (389)
Alabama (43)
Alaska (2)
Arizona (64)
Arkansas (9)
Asia (20298)
Australia (3683)
California (4373)
Canada (1279)
China (418)
Colorado (166)
Connecticut (179)
Delaware (117)
Europe (45333)
Florida (531)
Georgia (135)
Idaho (24)
Illinois (286)
India (15)
Indiana (168)
Iowa (4)
Japan (102)
Kansas (70)
Kentucky (6)
Louisiana (3)
Maine (20)
Maryland (574)
Massachusetts (3432)
Michigan (109)
Minnesota (192)
Mississippi (1)
Missouri (41)
Montana (16)
Nebraska (6)
Nevada (21)
New Hampshire (20)
New Jersey (1099)
New Mexico (12)
New York (1197)
North Carolina (626)
North Dakota (5)
Northern California (1931)
Ohio (132)
Oklahoma (10)
Oregon (24)
Pennsylvania (837)
Puerto Rico (6)
Rhode Island (20)
South America (470)
South Carolina (10)
Southern California (1669)
Tennessee (35)
Texas (525)
United States (15272)
Utah (93)
Virginia (91)
Washington D.C. (42)
Washington State (371)
West Virginia (2)
Wisconsin (25)
334,831 Results for "turning point therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Editorial
Doubts About Job Market Turning Around Soon Easy To Understand
In a recent
BioSpace
LinkedIn poll, nearly half of respondents predicted the job market won’t turn around until 2027 or later. It’s easy to see why people are skeptical, especially when you consider recent hiring activity and layoffs.
May 9, 2025
·
3 min read
·
Angela Gabriel
Press Releases
Turn Therapeutics Announces Vaccine Breakthrough: Validates 100% VSV Recovery from Petrolatum Carrier at 24 and 72 Hours
May 2, 2025
·
2 min read
Earnings
Bluebird Faces Cash Gap With Breakeven Point in Sight
Bluebird has just two quarters until it’s out of cash. Executives are looking for financing to extend that runway to a projected breakeven point before the end of 2025, with analysts worried they won’t make it.
November 15, 2024
·
4 min read
·
Annalee Armstrong
Artificial intelligence
Amid Layoffs, Delays, FDA Turns to AI for Speedy Reviews
The FDA expects to fully integrate its AI approach by June 30, though its different centers have been instructed to start the rollout immediately.
May 9, 2025
·
2 min read
·
Tristan Manalac
Biotech Beach
Turn Therapeutics Atopic Dermatitis Candidate Reduces Disease Severity by 57% In-Vivo
In a widely cited in-vivo model of atopic dermatitis, Turn Therapeutics’ atopic dermatitis candidate showed a dramatic reduction in disease severity versus placebo.
June 20, 2024
·
2 min read
Press Releases
AVAVA™ Receives FDA Clearance for Revolutionary Acne Scar Treatment using Focal Point Technology™
April 22, 2025
·
3 min read
Press Releases
SEKISUI Diagnostics to Provide Metrix® COVID/Flu Test to the Point-of-Care and Home Test Markets
April 3, 2025
·
3 min read
Press Releases
Ceribell Receives FedRAMP® High Authorization, Expanding Approval for Its AI-Powered Point-of-Care EEG Across Federal Healthcare Systems
May 1, 2025
·
6 min read
Editorial
This Might Be a Moot Point but the FDA’s Priority Review Vouchers Need Transparency
While Congress is renewing the priority review voucher program for rare pediatric diseases, the FDA should be required to keep public records of the passes changing hands, too.
March 7, 2025
·
3 min read
·
Annalee Armstrong
Press Releases
Equipment Junction Turns Surplus Lab Gear into STEM Opportunities
April 1, 2025
·
1 min read
1 of 33,484
Next
